key: cord-0985207-2tn9hlys
authors: Uhteg, Katharine; Carroll, Karen C.; Mostafa, Heba H.
title: Coronavirus Detection in the Clinical Microbiology Laboratory: Are We Ready for Identifying and Diagnosing a Novel Virus?
date: 2020-08-08
journal: Clin Lab Med
DOI: 10.1016/j.cll.2020.08.004
sha: 5dcfbd46e3dc4c72b811e005f8d33f5ceed0f36b
doc_id: 985207
cord_uid: 2tn9hlys

Endemic species of coronaviruses (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1) are frequent causes of upper respiratory tract infections. The molecular diagnosis of the four species has become integrated into most of the comprehensive respiratory molecular panels used for routine diagnosis. Three highly pathogenic coronaviruses have been associated with outbreaks and epidemics and have challenged clinical microbiology laboratories to quickly develop assays for diagnosis. Their initial characterization was achieved by molecular methods that included pan-coronavirus PCR, amplicon sequencing, and whole genome sequencing. Molecular diagnostic methods were developed and made available mainly at public health laboratories or the CDC. With the great advance in metagenomic whole genome sequencing directly from clinical specimens, diagnosis of novel coronaviruses could be quickly implemented into the workflow of managing cases of pneumonia of unknown etiology, which will markedly impact the time of the initial characterization and accelerate the initiation of outbreak control measures.

Coronaviruses were first described as viruses of animals, causing a wide spectrum of diseases that include gastroenteritis of pigs (Transmissible gastroenteritis virus and Porcine epidemic diarrhea virus), encephalitis in pigs (Porcine hemagglutinating encephalomyelitis virus), lethal peritonitis in cats (Feline infectious peritonitis virus), and bronchitis in chickens (Infectious bronchitis virus), among others (1) . However their potential to cause disease in humans was not described until the 1960s (2) . Seven human coronaviruses (HCoV) were identified, the first two of which, HCoV-OC43 and HCoV-229E, were isolated from patients with respiratory tract infections (3, 4) . Since then, these two coronaviruses were established as endemic strains associated with mild disease and it was not until 2003 that a third HCoV was identified as a cause of severe acute respiratory syndrome (SARS) (5, 6) . Two additional HCoVs were discovered in 2004 (HCoV-NL63) (7) and 2005 (HCoV-HKU1) (8) followed by the Middle East Respiratory Syndrome (MERS)-CoV that emerged in 2012 (9) . Recently (December of 2019), the 7 th HCoV (SARS-CoV-2), has emerged in Wuhan, China causing millions of confirmed cases with high mortality (the WHO has named the disease COVID-19) (10) .

Coronaviruses belong to the family Coronaviridae order Nidovirales. Two subfamilies make up the Coronaviridae family: Letovirinae and Orthocoronavirinae. Orthocoronavirinae has four genera: Alpha, Beta, Gamma, and Deltacoronaviruses. Coronaviruses that infect mammals belong to the Alpha and Betacoronaviruses genera (11) (Figure 1 ). (1, (12) (13) (14) (15) (16) (17) . Infection with endemic coronaviuses can be severe, and indeed the first isolation of HCoV-NL63 and HCoV-HKU1 were from cases of bronchiolitis and pneumonia (3, 8) . Although these endemic coronaviruses have the potential to cause severe disease, which is largely associated with immunocompromising conditions or young age (18) (19) (20) , these viruses received scant attention due to their association with milder disease in immunocompetent individuals. The outbreak of SARS in China in [2002] [2003] highlighted the potential of these and/or related viruses to cause outbreaks of severe disease, as more than 8,000 cases were diagnosed with close to a 10% case fatality rate (21) . This highly pathogenic strain that is believed to be transmitted to humans by direct contact with market civets (22) was controlled after the 2003 outbreak with no additional cases reported since 2004. In 2012, another highly pathogenic coronavirus, MERS-CoV was isolated from a patient with fatal pneumonia in Saudi Arabia (9) . This virus was traced to dromedary camels.

Apparently frequent transmission events of this virus to this Middle East species of camel have occurred (23, 24) . This virus has affected 2,494 individuals with new cases being diagnosed every month, mainly from Saudi Arabia (WHO-MERS-CoV), with a case fatality rate higher than SARS-CoV (~35%) (2) . In December 2019, a novel coronavirus (SARS-CoV-2) was first isolated from Wuhan city, China and rapidly millions of cases were reported from almost every country all over the world. This most novel coronavirus was characterized by extensive spread and apparently higher infectivity or more efficient human to human transmission. At the time of this submission (the 1 st of July, 2020), 511,860 deaths were associated with COVID-19 of a total of 10,501,482 confirmed global cases (https://coronavirus.jhu.edu/map.html).

Most of the animal and human coronaviruses are believed to originate from bats. Next genome sequencing (NGS) of the bat virome revealed that 35% are coronaviruses, more than 200 of which were novel species (25) . SARS-like CoV was isolated from the Chinese horseshoe bat years after the SARS-CoV outbreak and MERS-CoV was found to be related to viruses J o u r n a l P r e -p r o o f isolated from various bat species of the Vespertilionidae family (26) . In addition, sequences similar to HCoV-NL63 and HCoV-229E have been identified in other species of bats (25) . As human coronaviruses all have zoonotic origin, it is essential to understand the determinants of spillover from bats or other natural reservoirs to humans. Surveillance studies with thorough genomic characterization are vital to predict the next novel highly pathogenic coronavirus epidemic.

The viruses of the Coronaviridae family are enveloped with a single strand, positive sense RNA genome that has an average size of 30Kb (1). The name "corona" describes the crown shaped projections of the surface when visualized with electron microscopy. The genome has a 5'-terminal cap similar to the standard eukaryotic cap structure and a polyadenylated tail at the 3' end. About two thirds of the genome encodes for the replicase-transcriptase, which is the only protein that is immediately translated directly from the genome (encoded by open reading frames (ORF) 1a and 1b that encode for 16 non-structural proteins) ( Figure 2 ). Negative sense genomic and subgenomic RNAs are then synthesized with the help of the replicasetranscriptase that serves as the template for the production of all the downstream open reading frames (27) . At least five additional ORFs make up the remaining one third of the genome and encode for structural proteins that include: the spike (S), membrane (M), nucleocapsid (N), and envelope (E). Additional accessory genes are dispersed between the structural genes' ORFs downstream of the replicase which are group specific and required for efficient viral replication ( Figure 2 ). Transcription regulatory sequences are located between the ORFs that control transcription termination as well as the addition of the leader sequences. The structural protein coding region by sequence alignment of different coronaviruses appears less conserved than the non-structural protein encoding region; however both regions show less than 60% identity at J o u r n a l P r e -p r o o f the genomic level. Usually, the more conserved Orf1b is selected as a target for molecular assay design (21) .

Nucleic acid detection methods are more sensitive than traditional methods of diagnosis that include cell culture, and offer higher specificity. In general, there are three goals of molecular coronavirus diagnosis in the clinical microbiology and public health laboratories: routine diagnostics of endemic strains, the diagnosis of highly pathogenic strains in endemic areas and during outbreaks, and the detection and characterization of novel unidentified viruses. For coronavirus molecular identification, assays that could generally detect all known human coronaviruses as well as assays that could distinguish the different species were developed. In addition, NGS has advanced our understanding of new coronaviruses and showed a great potential in their identification directly from clinical specimens, although these assays have not yet entered routine practice in the clinical laboratory.

With the wide prevalence of endemic coronaviruses as significant causes of upper respiratory tract infection, implementing methods for routine diagnosis has become a common practice. Currently, diagnosing coronaviruses in the clinical microbiology laboratories is a part of most of the FDA cleared respiratory panel assays (table 1) . These panels usually are supplemented with oligonucleotides specific for the four endemic HCoVs. These assays usually target the N gene, however, several laboratory developed assays have used primers that target the polymerase, M, S genes, or the 5' UTR. The majority of these assays are multiplex or Most clinical microbiology laboratories do not offer testing for targeted detection of highly pathogenic HCoVs in house and in outbreak situations suspected specimens are sent out to either local public health laboratories or the CDC (table 1) . This work flow is challenging due to hurdles associated with specimen packaging and shipping in addition to prolonged turnaround times and their associated delay in making decisions related to patients' isolation. In response to the recent outbreak of COVID-19 several groups nationally and internationally attempted to develop diagnostic assays that could be available for all clinical laboratories, and multiple diagnostic providers within the US have been striving to receive EUA from the FDA.

This response was secondary to the quick spread of the disease, however it was also largely facilitated by the availability of the virus genomic sequences very quickly early in the pandemic.

RT-PCR assays developed by the Chinese national institute for viral disease control and prevention, the University of Hong Kong, and the US CDC (which received the EUA by FDA on gene has been used as a target for these pan-coronavirus molecular amplification methods with variable analytical performance (30, 31) . In general, these assays are useful for the identification of novel coronaviruses and could be used for an initial screening, however pancoronavirus detection approaches may suffer from lower sensitivity (32) .

Coronaviruses as a cause of seasonal respiratory tract diseases are largely restricted to the four endemic human coronaviruses. Up to date, three epidemics were caused by three novel highly pathogenic coronaviruses. The approaches for the initial characterization of these viruses varied. SARS-CoV was first identified by growing the virus in cell culture and using a random amplification PCR assay to amplify a 300 nucleotides region. A diagnostic RT-PCR J o u r n a l P r e -p r o o f assay was developed based on the obtained sequence (5) . A full genome was available shortly thereafter (6) and multiple specific nucleic acid amplification diagnostic assays were developed (33) . Conventional and molecular approaches were used for the classification of SARS-CoV as a member of Coronaviridae after about 6 weeks of the Hong Kong outbreak in mid-February 2003 (34) . In 2012, the identification of MERS-CoV that caused severe pneumonia and death of a 60 year old man was performed by a pan-CoV PCR assay after cell culture followed by amplicon sequencing (9) . An assay panel was developed for the detection of the N nucleocapsid and the upstream sequence (up) to the E envelope (upE) genes which has become the recommended test for the diagnosis of MERS-CoV by WHO (35) . Eighteen years after the SARS-CoV outbreak, a novel coronavirus was recognized as a cause of another epidemic of severe respiratory infection that started in Wuhan, China. Shortly after the outbreak, clinical specimens were tested both by a pan-CoV PCR assay and NGS. Subsequently, a specific RT-PCR was developed. The SARS-CoV-2 whole genome was available on January 10 th , almost one month after the first report of pneumonia of unknown origin. This was accelerated compared to SARS-CoV, of which a complete sequence was available on April 2003, a few months after the outbreak started late in 2002. The history of identifying novel epidemic coronaviruses highlights the great impact of using advanced metagenomic NGS (discussed below) not only for rapid identification, but also for the epidemiological tracing of the viral reservoir and for elucidating the transmission dynamics. 

Several studies showed the great potential of MinION in viral identification (42, 43) and confirmed its potential as a point of care test which included the identification of Chikungunya, Ebola, and hepatitis C (43) . Recently, diagnosis of influenza virus using MinION directly from respiratory specimens was successful with great sensitivity from specimens with higher viral loads (44) . In addition, a near complete influenza viral genome was reconstructed by MinION in this study as well as the detection of co-infecting viruses that included coronavirus and human metapneumovirus (44) .

The characterization of the most recent highly pathogenic coronavirus (SARS-CoV-2) was partially performed by MinION sequencing in addition to mNGS (45) . In addition, MinION was used in combination with Sanger based sequencing for the prospective analysis of specimens from suspected patients in Wuhan in order to characterize the epidemiology of SARS-CoV-2 transmission and to determine the potential for human to human transmission (46) .

The use of the MinION as a tool for quick investigation of a novel coronavirus not only has diagnostic potential, but also a huge epidemiological impact. A quick method for direct sequencing of clinical specimens is instrumental for understanding the transmission of the virus, its mutation rate, and polymorphisms associated with disease severity. The ARTIC network was initiated by a group of molecular biologists as a real-time molecular epidemiology response network for processing specimens during viral outbreaks. Based on Nanopore technology, this epidemiological screening network for viral outbreaks has become feasible in locations with limited resources and is mainly focused on the rapidly evolving RNA viruses. The overall goal is to collect sequencing information in a real-time format to allow the real-time understanding of viral transmission and evolution (https://artic.network/). The ARTIC group has started providing materials and support for sequencing the SARS-CoV-2 which includes primers, protocols, and pipelines for data analysis (47) .

Another great advantage for using Nanopore sequencing methods is the feasibility for direct RNA sequencing. This approach was used to obtain the whole genome of HCoV-229E

and was very successful in identifying, not only an accurately built scaffold for the genome, but also the several subgenomic length RNAs (48) . Like other RNA viruses, coronaviruses are characterized by high rates of recombination (49) 

Coronaviruses: an overview of their replication and pathogenesis

Hosts and Sources of Endemic Human Coronaviruses

A new virus isolated from the human respiratory tract

Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

Identification of a new human coronavirus

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China

Coronavirus genomics and bioinformatics analysis

Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction

Human coronaviruses associated with upper respiratory tract infections in three rural areas of Ghana

Similar virus spectra and seasonality in paediatric patients with acute respiratory disease, Ghana and Germany

New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia

Human coronavirus NL-63 infections in children: a 1-year study

Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method

The First Infant Death Associated With Human Coronavirus NL63 Infection

Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL

Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

MERS coronaviruses in dromedary camels

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

Bats and Coronaviruses

Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus

A contemporary view of coronavirus transcription

Molecular diagnosis of respiratory virus infections

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries

A pancoronavirus RT-PCR assay for detection of all known coronaviruses

No novel coronaviruses identified in a large collection of human nasopharyngeal specimens using family-wide CODEHOPbased primers

Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients

Molecular diagnosis of severe acute respiratory syndrome: the state of the art

Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV)

Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus

Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection

The 2019-new coronavirus epidemic: Evidence for virus evolution

Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China

Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit

Global Epidemiology of Bat Coronaviruses

Assessing the performance of the Oxford Nanopore Technologies MinION

Bacterial and viral identification and differentiation by amplicon sequencing on the MinION nanopore sequencer

Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis

Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory Samples

China Novel Coronavirus I, Research T. 2020. A Novel Coronavirus from Patients with Pneumonia in China

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

A proposal of an alternative primer for the ARTIC Network's multiplex PCR to improve coverage of SARS-CoV-2 genome sequencing

Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis

RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments

MERS coronavirus in dromedary camel herd, Saudi Arabia

Real-time reverse transcriptionpolymerase chain reaction assay for SARS-associated coronavirus

Clinical evaluation of a panel of multiplex quantitative real-time reverse transcription polymerase chain reaction assays for the detection of 16 respiratory viruses associated with community-acquired pneumonia

Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease